Need HELP! Let Us Call You Back...
Need HELP! Let Us Call You Back...
The Oculentis recall for the Lentis foldable Intraocular lenses initially stemmed from 2014 with an updated Field Safety Notice issued in 2017.
The Field Safety Notice confirms that surface calcification could lead to opacification, which could be the result of "phosphate remnants originating from a detergent previously used in the cleaning process of the IOL (intraocular lense)".
Oculentis has stopped using the cleaning detergent that may have been causing the Oculentis opacification problems. Oculentis accepted that the "opacification may compromise the optical transparency of the IOL in time, potentially leading to a slow reduction in the patient's visual acuity".
You could be entitled to thousands of pounds in damages by initiating your Oculentis compensation claim with us if you are one of the hundreds of people who have suffered opacification (cloudiness in the vision / blind spots) from intraocular lenses.
The surgically-implanted lenses, commonly used for procedures to correct problems like cataracts, can fail as a result of surface calcification. The calcification could be caused by a phosphate cleaning agent that was previously used in the manufacturing process of the lens.
The initial Oculentis recall took place in 2014, and an updated Field Safety Notice was issued in 2017. Opacification problems that could be related to the phosphate remnants have been identified, and patients who are suffering problems should seek immediate medical advice. It can take years for the symptoms to develop. In some cases, the problems can start more than five years after the initial surgery.
Oculentis is offering to pay for the costs of corrective surgery, but this is not enough for the victims who have to endure more invasive surgery. If you are affected by the Oculentis recall, we can help you make a claim for compensation.
You are entitled to make an Oculentis compensation claim on top of the costs of any surgery that may already have been paid for.
In a very similar group action we are still involved in, where we have recovered over £1.3m in damages for victims so far, we have been successful in obtaining compensation for the pain, suffering and loss of amenity in addition to the cost of revision surgery. A Claimant is entitled to damages for the pain and suffering of having to go through another surgical procedure to correct the problem, and the risks of further surgery are considered. This is known as a claim for General Damages.
You can also claim Special Damages for any further expenses and losses that you may incur. A common one may be lost earnings from time off work in the post-surgery period, or additional medical expenses or travel expenses to and from appointments.
Free surgery is simply not enough for the victims suffering from any Oculentis opacification problems that could arise from the recall. You're entitled to more, and we can help you obtain the damages you deserve.
Our Group Action Lawyers are satisfied that there is a case to answer for anyone who is suffering from the Oculentis opacification problems.
We have therefore agreed to offer No Win, No Fee representation for victims who initiate their compensation claim with us.
As with the other 40+ group actions we're fighting for justice in - and the actions we have settled - we've assessed the case and we consider there are grounds to make a claim. As big believers in access to justice, we are prepared to take cases forward on the basis that we can write off our legal fees if the case isn't successful where a Claimant agrees to, and abides by, our terms and conditions.
In other medical actions, we've had to write off legal fees as a result of problems obtaining compensation when the Defendant is uninsured and has gone into liquidation. We stick to our promises; even when a case should have won, and the issue was the Defendant escaping justice by closing their business.
We cannot stress just how important it is that you start your Oculentis compensation claim as soon as you possibly can.
In another Group Action we are working in, the primary court cut-off date passed at the end of October 2018. We are still receiving new enquiries from people who missed the deadline and want to claim. Unfortunately, we're having to turn them away because we have closed our books for new cases.
That action is one of the biggest consumer actions ever commenced in the High Court of Justice, and it is one we've been appointed to the Steering Committee leading the action. But it's the court that set the deadlines, and people will miss out.
In these types of claims, there can be multiple deadlines to hit. Missing a deadline could mean the difference between securing tens of thousands of pounds in compensation for your pain and suffering, or receiving absolutely nothing at all.
If you're serious about claiming if you're affected by the Oculentis recall, please contact the team as soon as you can.
You can start your Oculentis compensation claim quickly and easily by filling in an enquiry form below...
Fill out our quick call back form below and we’ll contact you when you’re ready to talk to us.
All fields marked * are required.
We are representing clients who have been victims of this year's Blackbaud data breach where information has been exposed as ...Sep 29, 2020
Our specialist team at the Group Action Lawyers represent victims for pelvic mesh compensation claims on a No Win, No Fee bas...Sep 22, 2020
We have a huge amount of experience when it comes to representing people for medical product compensation claims on a No Win,...Sep 15, 2020
You can start your No Win, No Fee Mercedes emissions claim for compensation with us today - quickly and easily. We are tak...Sep 08, 2020
We represent clients pursuing easyJet cyber-attack compensation claims as victims of the recently discovered incident that hi...Sep 01, 2020
If you have yet to start your BA data breach compensation claim, you still have the chance to sign-up and now and benefit fro...Aug 25, 2020
We are pleased to see the Mercedes emissions settlements that have taken place in the US, with $2.2bn set aside for resolving...Aug 19, 2020